Explore 23andMe genetic reports.
Take some time to download the report examples that interest you to better understand the types of information your patients receive and may wish to share with you.
Take some time to download the report examples that interest you to better understand the types of information your patients receive and may wish to share with you.
Each Genetic Health Risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. These reports are not intended to tell a person anything about his or her current state of health, or to be used to make medical decisions, including whether or not he or she should take a medication or how much of a medication should be taken.
Genetic Health Risk reports package insert
White Paper 23-15: Scientific Standards for 23andMe’s Health and Trait Reports
Variant(s) detected
Your patient has one or more of the variants we tested. They may be at increased risk for the condition based on this result. This doesn’t mean s/he will definitely develop the condition. Other factors may also affect their risk.
Result not determined
Your patient’s test result could not be determined. This can be caused by random test error or other factors that interfere with the test.
Webinar: 23andMe’s New FDA-Authorized BRCA1/BRCA2 (Selected Variants) Report
These reports include genetic variants that have been linked to recessive conditions and provide insight into carrier status for the conditions listed below. These reports include only a subset of possible variants that may be linked to a condition, and it is possible to have other variants not included in these reports. Those with a family history of any of these conditions or increased risk based on ethnicity or family origin and are considering having children should discuss options for comprehensive testing with their healthcare provider.
Note: Sample reports do not cover all possible test result outcomes, and for many reports, residual risk estimates vary by ethnicity.
Your patient does not have the variant(s) we tested. There is still a chance that the patient could have a variant not covered by this test.
1 Variant
Your patient is a carrier and could pass the variant on to each of their children.
2 Variants††
Your patient will most likely pass a variant on to each of their children.
Result not determined
Your patient’s test result could not be determined. This can be caused by random test error or other factors that interfere with the test.
† For some reports, a customer may receive a result indicating that they have two copies of a variant. In these cases, the customer will pass a variant on to each of his or her children.
†† For some reports, customers with two copies of a variant will also be told that they are at risk for developing symptoms of the condition.
These reports describe how genetics influence traits and conditions related to lifestyle and environment.
White Paper 23-17: The Science Behind 23andMe’s Genetic Weight Report
White Paper 23-15: Scientific Standards for 23andMe’s Health and Trait Reports
These reports help consumers learn about their origins and ancient ancestors based on their DNA.
White Paper 23-16: Ancestry Composition: A Novel, Efficient Pipeline for Ancestry Deconvolution
White Paper 23-05: Neanderthal Ancestry Inference
These reports are a fun way for consumers to learn about how genetics influence traits like eye color, hair texture and taste preference.
White Paper 23-15: Scientific Standards for 23andMe’s Health and Trait Reports
Our customers have access to their raw genetic data, which they can view or download from their 23andMe account. This data has undergone a general quality review; however, only a subset of markers have been individually validated for accuracy. As such, the data from 23andMe’s Browse Raw Data feature is suitable only for research and educational and informational use and not for medical, diagnostic or other use.
The raw data could include sensitive information. Within the data, your patients could discover sensitive information about themselves and family members with whom they share their DNA. For example, comparing data between family members could reveal non-paternity.
*The 23andMe PGS test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. The relevance of each report varies based on ethnicity. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. Our carrier status reports can be used to determine carrier status, but cannot determine if an individual has two copies of any genetic variant. These carrier reports are not intended to tell an individual anything about risk for developing a disease in the future or anything about the health of a fetus, or newborn child’s risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. These reports are intended to provide genetic information that can be used to inform lifestyle decisions and conversations with healthcare professionals, but are not intended to diagnose disease, determine medical treatment or medical intervention including whether to take a medication or how much of a medication to take, or tell the user anything about their current state of health. Any diagnostic or treatment decisions must be based on confirmatory prescription testing and/or other information that you determine to be appropriate for your patient, such as additional clinical testing and other risk factors that may affect individual risk and health care. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action.
For important information and limitations regarding other genetic health risk reports and carrier status reports, visit https://www.23andme.com/test-info/.
Watch on demand (1 hour, 2 minutes)